Evidence for a role of citrate synthase (CS) in cancer is sparse and controversial: CS was found to be increased in pancreatic ductal carcinoma[12] and renal oncocytoma[13] but downregulated in various cervical cancer cell lines[14]. The gene discussed is CS; the disease is cervical carcinoma.